Zusammenfassung
Nach einem gern zitierten Wort sollen wir uns Scit einigen Jahren im „goldenen Zeitalter der Polypeptid- und Proteinhormone“ befinden, von dem noch viele Überraschungen zu erwarten sind. Betrachtet man die Ergebnisse der analytischen und synthetischen Proteinchemie, so besteht in der Tat zu Optimismus aller Grund. Die Struktur von Insulin ist weitgehend aufgeklärt, nicht nur die Oligopeptidhormone des Hypophysenhinterlappens (HHL) sind synthetisiert worden, sondern kürzlich auch das in dieser Arbeit besprochene Polypeptidhormon ACTH. Die speciesspezifischen Besonderheiten der großmolekularen Proteinhormone, des gonadotropen Wachstums- und Parathormons sind bekannt, und mit allen Mitteln wird daran gearbeitet, tierisches Ausgangsmaterial auch für die Therapie des Menschen artgleich passend zu machen.
Aus der I. Medizinischen Universitätsklinik Frankfurt a. M. Direktor: Prof. Dr. F. Hoff.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Albright, F.: Cushing’s syndrome. Harvey Lect. 38, 123 (1942/43).
Astwood, E. B., M. S. Raben and R. W. Payne: Chemistry of corticotrophine. Recent Progr. Hormone Res. 7, 1 (1952).
Astwood, E. B., M. S. Raben and R. W. Payne and A. B. Grady: Purification of corticotropin with oxycellulose. J. Amer. chem. Soc. 73, 2969 (1951).
Bethtune, J. E., R. H. Despointes, H. N. Antoniades and D. H. Nelson: Corticotrophic activity of human plasma constituents. Proc. Soc. exp. Biol. (N. Y.) 97, 69 (1958).
Bethtune, J. E., D. H. Nelson and G. W. Thorn: Plasma ACTH in Addison’s disease and its modification by the administration of adrenal steroids. J. clin. Invest. 36, 1701 (1957).
Bierich, J. R., D. SchÖNberg, U. E. Eckler: Untersuchungen zur Dynamik des Hypophysennebennierenrindensystems. Dtsch. med. Wschr. 87, 8, 84 (1962).
Bissell, G. W., A. L. Scott, W. E. Farnsworth and I. Winkler: A preliminary study of the use of 2-Methyl-l,2-bis(3-Pyridyl)-l-Propanone (SU 4885) as a test of pituitary function in man. N. Y. St. J. Med. 59, 3596 (1959).
Bornstein, J., and P. Trewhella: Adrenocorticotropic activity of blood plasma extracts. Lancet 1950 II, 678.
Castor, C. W., B. L. Baker, D. J. Ingle and C. H. Li: Effect of treatment with ACTH or cortisone on anatomy of the brain. Proc. Soc. exp. Biol. (N. Y.) 76, 353 (1951).
Clayton, B. E.: Some observations on adrenocorticotrophin in blood. Proc. roy. Soc. Med. 51, 558 (1958).
Cohen, A. I., E. Bloch and E. Celozzi: In vitro response of functional experimental adrenal tumors to corticotropin (ACTH). Proc. Soc. exp. Biol. (N. Y.) 95, 304 (1957).
Cohen, A. I., and F. G. Sulman: Continuous i.V. ACTH infusion in small doses as a physiologic approach to treatment. J. clin. Endocr. 14, 440 (1954).
Cohen, R. B., W. B. Chapman and B. Castleman: Hyperadreno-corticism (Cushing’s disease): A study of surgically resected adrenal glands. Amer. J. Path. 35, 337 (1959).
Cooper, C. E., E. R. Rutherford and D. H. Nelson, zit. in D. H. Nelson: Disorders in ACTH-secretion in man. Metabolism 10, 893 (1961).
Cope, C. L.: Diagnostic use of adrenal inhibition in Cushing’s syndrome. Brit. med. J. 4986, 193 (1956).
Cox, G. S., I. R. Hodges and I. Vernikos: The effect of adrenalectomy on the circulating level of ACTH in the rat. J. Endocr. 17, 177 (1958).
Crispell, K. R., and W. Parson: Coexistence of Cushing’s syndrome and internal hydrocephalus produced by a cerebellar tumor. Amer. J. Med. 13, 247 (1952).
Crooke, A.: A change in the basophil cells of the pituitary gland common to conditions which inhibit the syndrome attributed to basophilic adenoma. J. Path. Bact. 41, 339 (1935).
Cushing, H.: Pituitary basophilism. J. Amer. med. Ass. 99, 281 (1932).
Daughaday, W. H.: Evidence for two corticosteroid binding systems in human plasma (Abstr.). J. Lab. clin. Med. 48, 799 (1956).
Dekanski, I. B., and M. I. Harvie: The quantitative assay of corticotrophin using rats treated with hydrocortisone acetate. Brit. J. Pharmacol. 15, 95 (1960).
Van Dyke, D. C., M. E. Simpson, C. H. Li and ST. M. Evans: Survival in the circulation of the growth and adrenocorticotropic hormone as evidenced by parabiosis. Amer. J. Physiol. 163, 297 (1950).
Eberlein, W. R., and A. M. Bongiovanni: Congenital adrenal hyperplasia with hypertension: Unusual steroid pattern in blood and urine. J. clin. Endocr. 15, 1531 (1955).
Ekman, H., B. Hakansson, I. D. Mccarthy, I. Lehmann and B. SjÖGren: Plasma 17-Hydroxycorticosteroids in Cushing’s syndrome. J. clin. Endocr. 21, 684 (1961).
Eiknes, K., and L. D. Clark, zit. Ekman U. Mitarb.: Metabolism of Cortisol in normal and stressed dogs. Endocrinology 63, 82 (1958).
Farmer, T. H.: Chromatographic studies with pig adrenocorticotropin. Biochem. J. 73, 321 (1959).
Farmer, T. H., S. R. Hill, J. A. Pittman and J. W. Herod: The plasma 17-OH corticosteroid response to corticotropin, SU 4885 and lipopolysaccharide pyrogen. J. clin. Endocr. 21, 433 (1961).
Fortier, C.: Note on the extraction and storage of the rat pituitary prior to in vitro assay for ACTH. Canad. J. Biochem. 37, 608 (1959 a).
Fortier, C., Pituitary ACTH and plasma free corticosteroids following bilateral adrenalectomy in the rat. Proc. Soc. exp. Biol. (N. Y.) 100, 13 (1959b).
Froesch, E. R., A. Labhart, R. Neher, A. Prader, U. W. Ziegler: Diagnostische Anwendung eines neuen Adrenostaticum. Schweiz, med. Wschr. 89, 1232 (1959).
Fujita, T.: Determination of corticotropin (ACTH) in human blood and urine by a modified oxycellulose method. J. clin. Endocr. 17, 512 (1957).
Ganong, W. F., and D. M. Hume: Absence of Stress-induced and “compensatory” adrenal hypertrophy in dogs with hypothalamic lesions. Endocrinology 55, 474 (1954).
Garmendia, F., W. E. Vaubel, H. Bubser U. E. F. Pfeiffer: Über das Verhalten der endogenen ACTH-Aktivität im menschlichen Plasma nach enzymatischer Blockade der Cortisol-Synthese mit Metopiron (SU 4885). II. Untersuchungen bei Cushing-Patienten. Klin. Wschr. 41, 321 (1963).
Garmendia, F., W. E. Vaubel, u. E. F. Pfeiffer: Über das Verhalten der endogenen ACTH-Aktivität im menschlichen Plasma nach enzymatischer Blockade der Cortisol-Synthese mit Metopiron (SU4885). I. Untersuchungen an Stoffwechselgesunden. Klin. Wschr. 41, 317 (1963).
Gemzell, C. A., D. C. Van Dyke, C. A. Tobias and H. M. Evans: Increase of the formation and secretion of ACTH following adrenalectomy. Endocrinology 49, 325 (1951).
Geschwind, J. I., and Ch. H. Li: Inactivation of adrenocorticotrophic hormone in vitro by tissues. Endocrinology 50, 226 (1952).
Gold, E. M., V. C. Di Raimondo and P. H. Forsham: Quantitation of pituitary corticotropin reserve in man by use of an adrenocortical 11-beta-Hydroxylase inhibitor (SU4885). Metabolism 9, 3 (1960).
Gold, E. M., J. R. Kent and P. H. Forsham: Clinical use of a new diagnostic agent, metapirone (SU 4885) in pituitary and adrenal disorders. Ann. intern. Med. 54, 175 (1961).
Gray, C. H., and D. M. V. Parrott: Observations on a method of measuring adrenocorticotrophic hormone in plasma. J. Endocr. 9, 236 (1953).
Greenspan, F. S., C. H. Li and H. M. Evans: Disappearance rate of ACTH from rat’s plasma after i.V. injection. Endocrinology 46, 261 (1950).
Grumbach, M. M., A. M. Bongiovanni, W. R. Eberlein, J. J. Van Wyk and L. Wilkins: Cushing’s syndrome with bilateral adrenal hyperplasia: A study of the plasma 17-hydroxy-corticosteroids and the response to ACTH. Bull. Johns Hopk. Hosp. 96, 116 (1955).
Guillemin, R., O. W. Clayton, I. D. Smith and H. S. Lipscomb: Study of adrenal cortex function by simultaneous measurement of corticosterone in peripheral blood and adrenal ascorbic acid. C. R. Acad. Sci. (Paris) 245, 1834 (1957).
Hale, H. B., G. Sayers, K. L. Sydnor, M. L. Sweat and D. D. Van Fossan: Blood adrenocorticotropic hormone and plasma corticosteroids in men exposed to adverse environmental conditions. J. clin. Invest. 36, 1642 (1957).
Hamburger, C.: Assay of corticotrophin prednisolone pretreatment instead of hypophysectomy in the adrenal Ascorbic acid depletion test. Acta endocrin. 35, 594 (1960).
Heinbecker, P.: Pathogenesis of Cushing’s syndrome. Medicine 23, 225 (1944).
Henke, W. J., R. P. Doe and M. E. Jacobsohn: A test of pituitary reserve utilizing intravenous SU 4885 with a new method for extraction of 11-Desoxy corticosteroids. J. clin. Endocr. 20, 1527 (1960).
Hodges, J. R., and J. Vernikos: Influence of circulating ACTH on the pituitary ACTH response to stress in the adrenalectomized rat. Nature (Lond.) 182, 725 (1958).
HÖKfelt, B., and R. Luft: The effect of suprasellar tumors on the regulation of adreno-cortical functions. Acta endocr. (Kbh.) 32, 177 (1959).
Hoff, F.: Medizinische Klinik. Ein Fortbildungskurs für Ärzte und Studierende. Stuttgart: Thieme 1948.
Hoff, F.: Die Klinik der Nebennieren und ihre Korrelationen, p. 90. Freiburger Tagung der Dtsch. Ges. Pathol. 3.–7. 6. 1952.
Hoff, F.: Klinische Physiologie und Pathologie, 2.–6. Aufl. Stuttgart: Thieme 1952/62.
Jailer, J. W., I. I. Gold and E. Z. Wallace: Evaluation of the “cortisone-test” as a diagnostic aid in differentiating adrenal hyperplasia from adrenal neoplasia. Amer. J. Med. 16, 340 (1954).
Jailer, J. W., and D. A. Holub: The significance of pituitary tumors in Cushing’s syndrome. Programm I. Intern. Endokrinologen-Kongress, Kopenhagen, Juli 1960, Abstr. Nr. 182.
Jailer, J. W., D. Longson and N. P. Christy: Studies in Cushing’s syndrome. II. Adrenal weight-maintaining activity in the plasma of patients with Cushing’s syndrome. J. clin. Invest. 36, 1608 (1955).
Jenkins, J. S., J. W. Meakin and G. H. Nelson: A comparison of the inhibitory effects of 2-methyl-l,2-bis(3-Pyridyl)-I-Propanone and amphenone on adrenal cortical secretion in the dog. Endocrinology 64, 572 (1959).
Jenkins, J. S., J. W. Meakin and G. H. Nelson and G. W. Thorn: Inhibition of adrenal steroid 11-Oxygenation in the dog. Science 128, 478 (1958).
Jenkins, J. S., L. Pothier, W. J. Reddy, D. H. Nelson and G. W. Thorn: Clinical experience with selective inhibition of adrenal function. Brit. med. J. 1959 I, 358.
Jores, A.: Über Hormonuntersuchungen bei Morbus Cushing. Klin. Wschr. 14, 1348 (1935).
Jores, A.: Krankheiten der Hypophyse und des Hypophysenzwischenhirnsy stems. Handb. d. inn. Med., 4. Aufl. VII/1. Berlin-Göttingen-Heidelberg: Springer 1955a.
Jores, A.: Die Nebennieren und ihre Krankheiten. Handb. d. inn. Med., 4. Aufl. VII/1. Berlin-Göttingen-Heidelberg: Springer 1955 b.
Kleinfelder, H., H. Bracharz U. E. Gebert: Die Bestimmung der hypophysären ACTH-Reserve it SU 4885 (Metopiron). Klin. Wschr. 39, 1153 (1961).
Kracht, I., u. I. Tamm: Bilaterale kleinknotige Adenomatöse der Nebennierenrinde bei Cushing-Syndrom. Virchows Arch. Path. Anat. 333, 1 (1960).
Laidlaw, J. C., W. J. Reddy, D. Jenkins, N. Abu Hajdar, A. E. Renold and G. W. Thorn: Advances in the diagnosis of altered states of adrenocortical function. New Engl. J. Med. 253, 747 (1955).
Laqueur, G. L.: The human hypophysis in disease of the adrenal cortex. Stanf. med. Bull. 9, 75 (1951).
Leeman, S. E., D. W. Glenister and F. E. Yates: Evidence for a central nervous system site of corticosterone inhibition of adrenocorticotrophin (ACTH) release. Fed. Proc. 20, 184 (1961).
Levine, R., and M. Smith: Cushing’s syndrome, in: Clinical Endocrinology I, p. 344, E. B. Astwood Ed. New York-London: Grune & Stratton 1960.
Li, Ch. H.: Adrenocorticotropic XIX-Esterfied Adrenocorticotropin. J. biol. Chem. 235, 1383 (1960).
Liddle, G. W.: Test of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J. clin. Endocr. 20, 1539 (1960).
Liddle, G. W., H. L. Estep, J. W. Kendall, W. C. Williams Jr. and A. W. Townes: Clinical application of a new test of pituitary reserve. J. clin. Endocr. 19, 875 (1959).
Liddle, G. W., D. Island, E. M. Lance and A. P. Harris: Alternations of adrenal steroid-patterns in man resulting from treatment with a clinical inhibitor of 11-ß-Hydroxylation. J. clin. Endocr. 18, 906 (1958).
Liddle, G. W., W. C. Williams Jr. U. A. Walser (a): Die Bedeutung von ACTH für die Pathogenese der Cushingschen Erkrankung. Schweiz, med. Wschr. 90, 1325 (1960).
Liddle, G. W., D. Island U. A. Walser (b): SU 4885 (Metopiron)-Test zur Bestimmung der Hypophysen-Nebennieren-Reserve. Schweiz, med. Wschr. 90, 1351 (1960).
Lipscomb, H. S., and D. H. Nelson: Measurement of corticosterone in rat adrenal venous plasma as bioassay for ACTH. Fed. Proc. 18, 95 (1959).
Mason, H. L., and R. G. Sprague: Isolation of 17-OH-corticosterone from urine in case of Cushing’s syndrome associated with severe diabetes mellitus. J. biol. Chem. 175, 451 (1948).
Meakin, J. W., and D. H. Nelson: The catabolism of ACTH: some characteristics of an ACTH-inactivating system in plasma. Endocrinology 66, 73 (1960).
Meakin, J. W., W. H. Tingey and D. H. Nelson: Inactivation of ACTH. Program 40th Meeting of the Endocrine Society, San Francisco, June 19–21, 1958, Abstract No. 88.
Meakin, J. W., J. E. Bethune, R. H. Despointes and D. H. Nelson: The rate of disappearance of ACTH activity from the blood of human (letter on the editor). J. clin. Endocr. 19, 1491 (1959).
Mellinger, R. C., and R. W. Smith: Studies of the adrenal hyperfunction in 2 patients with atypical Cushing’s syndrome. J. clin. Endocr. 16, 350 (1956).
Mosier, D. H., J. F. Pierce, D. W. Will and R. D. Turner: Cushing’s syndrome with multinodular adrenal glands. J. clin. Endocr. 20, 632 (1960).
Mulrow, P. J., and G. L. Cohn: Corticosteroid release and synthesis in vitro by adrenal slices from patients with Cushing’s syndrome. J. clin. Invest. 40, 1250 (1961).
Munson, P. L., and W. Toepel: Detections of minute amounts of adrenocorticotropic hormone by the effect on adrenal venous ascorbic acid. Endocrinology 63, 785 (1958).
Nelson, D. H.: Corticotropin in human plasma, in: Clinical endocrinology I, p. 626–636, E. B. Astwood Ed. New York-London: Grune & Stratton 1960.
Nelson, D. H.: Disorders of ACTH-Secretion in man. Metabolism 10, 894 (1961).
Nelson, D. H. and D. M. Hume: Corticosteroid secretion in the adrenal venous blood of the hypophysectomized dog as an assay for ACTH. Endocrinology 57, 184 (1955).
Nelson, D. H., J. W. Meakin, J. B. Dealy, D. D. Matson, K. Emerson and G. W. Thorn: ACTH-producing tumor of the pituitary gland. New Engl. J. Med. 259, 161 (1958).
Nelson, D. H., J. W. Meakin, and G. W. Thorn: ACTH-producing tumors following adrenalectomy for Cushing’s syndrome. Arch, intern. Med. 52, 560 (1960).
Nugent, Ch. A., K. Eik-Nes, H. S. Kent, L. T. Samuels and F. H. Tyler: A possible explanation for Cushing’s syndrome associated with adrenal hyperplasia. J. clin. Endocr. 20, 1259 (1960).
Nugent, Ch. A., L. T. Samuels and F. H. Tyler: Changes in plasma levels of 17-OH-Corticosteroids during the i.V. administration of ACTH. IV. Response to prolonged infusions of small amounts of ACTH. J. clin. Endocr. 19, 334 (1959).
Paris, J., M. Upson Jr., R. G. Sprague, R. M. Salassa and A. Albert: Corticotropic activitv of human blood. J. clin. Endocr. 14, 597 (1954).
Perkoff, G. T., K. Eik-Nes, C. A. Nugent, H. L. Fred, R. A. Nimer, L. Rush and F. H. Tyler: Studies of the diurnal variation of plasma 17-OH-corticosteroids in man. J. clin. Endocr. 19, 432 (1959).
Pfeiffer, E. F.: Unveröffentlicht (1956).
Pfeiffer, E. F.: Die Bedeutung des Hormonlaboratoriums für Diagnose und Therapie endokriner Erkrankungen. Therapiewoche 9, 12, 18 (1959).
Pfeiffer, E. F.: W. E. Vaubel, K. Retiene, D. Berg U. H. Ditschuneit: ACTH-Bestimmung mittels Messung des Plasma-Corticosterons der mit Dexamethason hypophysenblockierten Ratte. Klin. Wschr. 38, 980 (1960).
Pharmacopoia of the United States, 16th Revision 1960.
Pincus, G.: Discussion in adrenal cortex, p. 42, in: Transactions of the Second Conference, ed. by Ralli, E. P., N. Y., Josiah Macy, Jr. Foundation, 1950.
Pincus, G., T. F. Hopkins and O. Hechtee: An ACTH-inactivating factor in mammalian blood. Arch. Biochem. 37, 408 (1952).
Plotz, C. M., I. Knowlton and C. Ragan: The natural history of Cushing’s syndrome. Amer. J. Med. 13, 597 (1952).
Purvis, H. D., and D. D. Adams: Thyroid stimulating hormone. Brit. med. Bull. 16, 128 (1960).
Di Raimondo, V., R. H. Oro, D. Island and P. H. Forsham: Kinetics of human adrenal cortical activity. J. clin. Invest. 34, 930 (1955).
Reiss, M., F. W. Badrick, I. D. K. Hlakerston and C. Plaice: Inactivation of ACTH by plasma. Nature (Lond.) 168, 206 (1951).
Rerup, C., and P. Hedner: On the assay of corticotrophin: Comparison of the plasma corticosteroid and adrenal ascorbic acid response. Acta endocr. (Kbh.) 38, 220 (1961).
Retiene, K., H. Ditschuneit, M. Fischer, K. Kopp U. E. F. Pfeiffer: ACTH-Bestimmung anhand des Corticosteronanstiegs im Nebennierenvenenblut hypophysektomierter Ratten. Vergleich von Dexamethasonblockade und Hypophysektomie. 8. Symp. Dtsch. Ges. Endokrinol. 1.–3. 3. 1961, München, p. 427, Berlin-Göttingen-Heidelberg: Springer 1962.
Retiene, K., A. Espisoza, Y. Abdel Rahman, K. H. Marx U. E. F. Pfeiffer: Untersuchungen über den Transport und die Tagesrhythmik von endogenem ACTH im Blut von Stoffwechselgesunden und Cushing-Kranken, 10. Symp. Dtsch. Ges. Endokrinol., Wien, 7–9. März 1963 (im Druck).
Retiene, K., M. Fischer, H. Dischuneit U. E. F. Pfeiffer: Biologische Halbwertzeit von exogenem ACTH im menschlichen Blut. 9. Symp. Dtsch. Ges. Endokrinol. Wiesbaden/Mainz, 3.–5. 5. 1962 (im Druck).
Richards, J. B., and G. Sayers: Fate and excretion of ACTH. Proc. Soc. exp. Biol. (N. Y.) 77, 87 (1951).
Romanoff, E. B., P. Hudson and G. Pinkus: Isolation of hydrocortisone and corticosterone from human adrenal vein blood. J. clin. Endocr. 13, 1546 (1953).
Saffran, M.: Hormonal functions of the hypothalamus. Erg. inn. Med., N. F. 10, 594 (1958).
Saffran, M., and A. V. Schally: In vitro bioassay of corticotropin: Modification and statistical treatment. Endocrinology 56, 523 (1955).
Sandberg, A. A., D. H. Nelson, E. M. Glenn, F. H. Tyler and L. T. Samuels: 17-Hydroxycorticosteroids and 17-Ketosteroids in urine of human subjects: clinical application of a method employing β-glucuronidase hydrolysis. J. clin. Endocr. 13, 1445 (1953).
Sayers, G.: Hypothalamus and adenohypophysis: with special reference to corticotropin release: First Intern. Congr. Endocrinol. Copenhagen, July 1960, Symposium I, Lecture 4, p. 25.
Sayers, G., T. W. Burns, F. H. Tyler, B. V. Jager, T. B. Schwartz, E. L. Smith, L. T. Samuels and H. W. Davenport: Metabolic actions and fate of i. v. administered ACTH in man. J. clin. Endocr. 9, 593 (1949).
Sayers, G., and P. C. Royce: Regulation of the secretory activity of the adrenal cortex, in: Clin. Endocrin. I. p. 323, E. B. Astwood Ed., New York-London: Grune & Stratton 1960.
Sayers, M. A., G. Sayers and L. A. Woodbury: The assay of pituitary adrenocorticotrophic hormone by the adrenal ascorbic acid depletion method. Endocrinology 42, 379 (1948).
Segaloff, A.: Requirements for clinically useful endocrine bioassays. Ciba Foundation Coll. Endocrinol. 5, 1 (1953).
Silber, R. H., R. D. Bush and R. Oslapas: Practical procedure for estimation of corticosterone or hydrocortisone. Clin. Chem. 4, 278 (1958).
Silber, R. H., and C. Porter: The determination of 17,21-Dihydroxy-20-Ketosteroids in urine and plasma. J. biol. Chem. 210, 923, (1954).
Slaunwhite, W. R. Jr., and A. A. Sandberg: Transcortin: a corticosteroid-bindung protein of plasma. J. clin. Invest. 38, 384 (1959).
Soffer, L. J., R. I. Dorfman and J. L. Gabrilove: The human adrenal gland. Philadelphia: Lea & Febiger 1961.
Sonnenberg, M., A. S. Keston and W. L. Money: Studies with labelled anterior pituitary preparations: adrenocorticotropin. Endocrinology 48, 148 (1951).
Squire, PH. G., and Ch. H. Li: Purification and properties of interstitial cell-stimulating hormone from sheep pituitary glands. J. biol. Chem. 234, 520 (1959).
Staudinger, HJ., U. V. Bauer: Zur Bestimmung der an Glucuronsäure gebundenen Corticoide im Harn. Klin. Wschr. 32, 330 (1954).
Steelman, S. L., and R. Guillemin: Adrenocorticotropic activity of alpha-melanocyte stimulating hormone (Alpha-MSH). Proc. Soc. exp. Biol. (N. Y.) 101, 600 (1959).
Sweat, M. L.: Sulfuric acid induced fluorescence of corticosteroids. Analyt. Chem. 25, 773 (1954).
Sydnor, K. L., V. C. Kelley, R. B. Raile, R. S. Ely and G. Sayers: Blood adrenocorticotropin in children with congenital hyperplasia. Proc. Soc. exp. Biol. (N. Y.) 82, 695 (1953).
Sydnor, K. L., and G. Sayers: Technique for determination of adrenocorticotropin in blood. Proc. Soc. exp. Biol. (N. Y.) 79, 432 (1952).
Sydnor, K. L., Biological half-life of endogeneous ACTH. Proc. Soc. exp. Biol. (N. Y.) 83, 729 (1953).
Sydnor, K. L., H. Brown and F. H. Tyler: Preliminary studies on blood ACTH in man. J. clin. Endoer. 13, 891 (1953).
Tamm, I.: Zur Pathogenese des Cushing-Syndroms infolge bilateraler NNR-hyperplasie. Dtsch. med. Wschr. 86, 1874 (1961).
Tamm, I., D. Busch U. K. D. Voigt: Das Verhalten der freien und gebundenen 17-OH-Corticosteroide in Plasma und Urin unter intravenösen Gaben von ACTH. Klin. Wschr. 36, 297 (1958).
Taylor, A. B., A. Albert and R. G. Sprague: Adrenotrophic activity of human blood. Endocrinology 45, 335 (1949).
Thorn, G. W., D. Jenkins and J. C. Laidlaw: The adrenal response to stress in man. In: Recent progress in hormone research. Vol. 8, p. 171. New York: Academic Press Inc. 1953.
Vance, V. K., W. J. Reddy, D. H. Nelson and G. W. Thorn: The estimation of ACTH in human plasma. Programm der 42. Tagung der American Endocrine Society, Miami, 9.–11. Juni 1960, Abstr. Nr. 28.
Vaubel, E., D. Berg, K. Retiene, H. Ditschuneit U. E. F. Pfeiffer: ACTH-Bestimmung mittels fluorometrischer Messung des Plasmacorticosterons der Ratte nach Hypophysenblockade mit Dexamethason. Programm I. Intern. Endocrinologen-Kongreß, Kopenhagen, Juli 1960, Abstr. Nr. 567.
Voigt, K. D., A. Oriol-Bosch U. J. Tamm: Untersuchungen über den Einfluß einer intravenösen ACTH-Infusion auf die Plasma- und Urinsteroide von behandelten und unbehandelten Patienten mit Cushing-Syndrom. Klin. Wschr. 38, 206 (1960).
Waxmann, S. H., D. E. Tippit and V. C. Kelle Y: Indépendant estimation of 11-desoxycortisol and Cortisol in a single plasma sample. J. clin. Endoer. 21, 943 (1961).
Williams, W. C. Jr., D. Island, R. A. H. Oldfield and G. W. Liddle: Blood corticotropin (ACTH) levels in Cushing disease. J. clin. Endoer. 21, 426 (1961).
Zenker, N., and D. E. Bernstein: The estimation of small amounts of corticosterone in rat plasma. J. biol. Chem. 231, 695 (1958).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1963 Springer-Verlag OHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Pfeiffer, E.F., Garmendia, F., Vaubel, E., Retiene, K. (1963). Exogene und endogene ACTH-Aktivitäten im nativen Plasma des Menschen. In: Heilmeyer, L., Schoen, R., De Rudder, B., Prader, A. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94862-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-94862-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94863-3
Online ISBN: 978-3-642-94862-6
eBook Packages: Springer Book Archive